Two-dose of #Covaxin, Developed by #Hyderabad-based #BharatBiotech, Provided Only 50 % ... - Latest Tweet by IANS India

Two-dose of #Covaxin, developed by #Hyderabad-based #BharatBiotech, provided only 50 % protection against the #COVID19 infection during the second wave of the pandemic in #India, according to the first real-world assessment published in The Lancet Infectious Diseases journal. pic.twitter.com/hU7EOZNQvJ— IANS Tweets (@ians_india) November 24, 2021

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)